Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
All content curated by
Rafael Fonseca MD
Rafael Fonseca MD
Alexander van Akkooi MD, PhD, FRACS
Alexander van Akkooi MD, PhD, FRACS
See All Experts
Published in Oncology

Journal Scan / Research · September 09, 2024

Patients Characteristics and Impact of Immunotherapy on Outcomes of SCLC Over 20 Years in a Real-Life Setting

European Journal of Cancer

 

 Save  Recommend
 Share

Additional Info

European Journal of Cancer
Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting
Eur. J. Cancer 2024 Aug 14;210(xx)114277, L Falchero, N Meyer, O Molinier, F Al Freijat, H Pegliasco, E Lecuyer, L Stoven, L Belmont, S Loutski, C Maincent, AS Blanchet-Legens, A Mairovitz, F Meniai, S Hominal, A Letierce, H Morel, D Debieuvre

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated